Kezar to discontinue mid-stage trial for lupus treatment

Kezar Life Sciences

17/10/2024 13:45

Oct 17 (Reuters) - Kezar Life Sciences  KZR.O  said on
Thursday it would terminate its mid-stage trial studying its
experimental drug in patients with active lupus nephritis and
focus on the development of the drug in autoimmune hepatitis.

 (Reporting by Sriparna Roy in Bengaluru; Editing by Shilpi
Majumdar)
 ((Sriparna.Roy@thomsonreuters.com;))